BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient.
暂无分享,去创建一个
H. Nakasone | K. Kawamura | J. Kanda | K. Ohashi | T. Ichinohe | S. Seo | Y. Atsuta | K. Matsuoka | T. Fukuda | K. Yakushijin | F. Kimura | Masatsugu Tanaka | Y. Inamoto | H. Nakamae | M. Ogata | S. Ota | N. Uchida | A. Shinohara | Akihito Shinohara
[1] J. Ritz,et al. A confirmation of chronic graft-versus-host disease prediction using allogeneic HY antibodies following sex-mismatched hematopoietic cell transplantation , 2019, Haematologica.
[2] D. Stroncek,et al. Sources of Hematopoietic Stem and Progenitor Cells and Methods to Optimize Yields for Clinical Cell Therapy. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[3] L. Tian,et al. Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes , 2016, Haematologica.
[4] L. Tian,et al. Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy , 2015, Haematologica.
[5] D. Miklos,et al. Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans. , 2015, Blood.
[6] S. Theurich,et al. Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults - a systematic review and meta-analysis. , 2015, Critical reviews in oncology/hematology.
[7] D. Miklos,et al. Therapeutic benefits targeting B-cells in chronic graft-versus-host disease , 2015, International Journal of Hematology.
[8] Tao Wang,et al. Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[9] J. Kanda. Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation , 2015, International Journal of Hematology.
[10] Y. Atsuta. Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data) , 2015, International Journal of Hematology.
[11] M. Horowitz,et al. Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. , 2014, Blood.
[12] D. Miklos,et al. Clinical impact of H-Y alloimmunity , 2014, Immunologic research.
[13] H. Nakasone,et al. Risk factors and organ involvement of chronic GVHD in Japan , 2014, Bone Marrow Transplantation.
[14] D. Miklos,et al. H–Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease , 2013, Proceedings of the National Academy of Sciences.
[15] J. Ferrara,et al. Advances in predicting acute GVHD , 2013, British journal of haematology.
[16] Y. Kanda,et al. Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.
[17] L. Zhao,et al. Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT. , 2012, Blood.
[18] R. Storb,et al. Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow. , 2012, Blood.
[19] W. Bensinger. Allogeneic transplantation: peripheral blood vs. bone marrow , 2012, Current opinion in oncology.
[20] M. Horowitz,et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. , 2012, Blood.
[21] Yingjun Chang,et al. Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials , 2012, Annals of Hematology.
[22] M. Kurokawa,et al. The negative impact of female donor/male recipient combination in allogeneic hematopoietic stem cell transplantation depends on disease risk , 2011, Transplant international : official journal of the European Society for Organ Transplantation.
[23] R. Storb,et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. , 2011, Blood.
[24] B. Djulbegovic,et al. Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[25] B. Sandmaier,et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[26] E. Holler,et al. Graft-versus-host disease , 2009, The Lancet.
[27] K. Kawa,et al. Unification of Hematopoietic Stem Cell Transplantation Registries in Japan and Establishment of the TRUMP System , 2007, International journal of hematology.
[28] R. Hills,et al. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] N. Kröger,et al. The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants , 2005, Bone Marrow Transplantation.
[30] M. Sorror,et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. , 2005, Blood.
[31] Catherine J. Wu,et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. , 2004, Blood.
[32] F. Appelbaum,et al. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. , 2004, Blood.
[33] T. Panzarella,et al. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. , 2002, Blood.
[34] C Anasetti,et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. , 2001, Blood.
[35] S. Singhal,et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial , 2000, The Lancet.
[36] E D Thomas,et al. 1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.
[37] K. Sullivan,et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.